| Similar Articles |
|---|
 |
Managed Care
March 2007
Lola Butcher |
Plans Put Greater Emphasis On Cancer Management Increasingly, health plans are rolling out services designed to help cancer patients and, before that, plan members at a high risk of cancer, to improve their health care and, in doing so, limit costs.   |
Managed Care
April 2004
Martin Sipkoff |
Plans Go Directly to Patients, Describing Treatment Options HMOs are developing programs that encourage patients to question their physicians about their treatment options. Doctors are wary. |
The Motley Fool
June 28, 2010
Luke Timmerman |
Orexigen Drug Shows Potential as "Two-Fer" Against Obesity and Diabetes Orexigen's latest drug aims at treating both diabetes and obesity. |
The Motley Fool
March 18, 2005
Stephen D. Simpson |
Managing the Unmanageable American Healthways is the leader in a whole new way of taking care of people. These shares aren't for the faint of heart, but growth investors should dig in and see for themselves if these shares could make their portfolio a bit healthier. |
Pharmaceutical Executive
August 1, 2008
Gayle Lorenzi et al. |
Spanning the Treatment Gap How a diabetes field team helped docs overcome the treatment gap. |
Fast Company
April 2012
Christina Chaey |
Stevi Riel Provides Partnerships With Hospitals To Find Affordable Help For Patients This year, the U.S. government started a program for health-care innovators. One innovator, Stevi Riel takes what physicians are too busy to do, and partners with hospitals to find affordable prescription solutions for underinsured patients. |
Managed Care
February 2001
Michael S. Victoroff |
Helping Patients Make Informed Decisions Now Harder Thanks to Range of Treatment The duty of informed consent necessitates that physicians discuss with their patients the realistic expectations and risks associated with treatment. When no protocol shows a distinct advantage, there is no duty to inform, which creates an ethical problem for physicians... |
The Motley Fool
September 23, 2010
Brian Orelli |
Ugly Side Effects Won't Derail This Drug Side effects don't matter much when there are no other treatment options, as in Cushing's disease. |
BusinessWeek
June 12, 2006
Michael Arndt |
Big Pharma's Nurse Will See You Now Drug companies are hiring RNs to educate patients - and boost marketing. |
Pharmaceutical Executive
February 1, 2007
Iaquinto & Palmisano |
Medical Education: A Platform for Success By pumping the science behind a brand, pharmaceutical companies can garner early loyalist - before a drug even hits the market. |
Wired
October 2006
Thomas Goetz |
The Thin Pill 75 million Americans may have something called metabolic syndrome. How Big Pharma turned obesity into a disease - then invented the drugs to cure it. |
American Family Physician
January 1, 2002
Susan Z.
Yanovski |
Medical Care for Obese Patients: Advice for Health Care Professionals More than 60 percent of adults in the United States are overweight or obese, and obese persons are more likely to be ill than those who are not. Obesity presents challenges to physicians and patients and also has a negative impact on health status... |
Managed Care
December 2003
Martin Sipkoff |
Health Plans Begin To Address Chronic Care Management As with so much else in health care, observing protocols, analyzing data, and rethinking benefit designs are important. |
Fast Company
April 2012
Christina Chaey |
Srikant Iyer Streamlines Patient Care In Hectic Emergency Rooms This health-care innovator uses a different kind of triage system to identify who is very ill and who is mildly ill, keeping emergency room care moving. |
The Motley Fool
August 10, 2010
Ryan McBride |
Vertex's Telaprevir Clears Hurdle, Could Halve Treatment Times for Hepatitis C Study results are positive. |
Managed Care
May 2007
Rachel M. Renshaw |
Keys to Diabetes Control? Patience, Persistence, and Perseverance Careful attention to a comprehensive treatment plan could forestall or prevent the need to add drugs and costs to a patient's regimen. |
Managed Care
October 2000 |
Diabetes Cases Up 33 Percent In Just 8 Years In findings that are likely to have serious implications for treatment-costs, adult incidence of diabetes rose 33 percent from 1990 to 1998, according to the U.S. Centers for Disease Control... |
The Motley Fool
June 3, 2011
Brian Orelli |
FDA Bullies Obesity Drugmakers It's been clear for some time that the Food and Drug Administration isn't particularly fond of obesity drugs. Now it's just being a bully. |
Pharmaceutical Executive
January 1, 2006
Gina Ashe |
Alternative Media: Patient Bloggers on Your Brands Find out what patient bloggers are saying about your pharmaceutical brands. |
Managed Care
January 2006
Martin Sipkoff |
Skeptics Abound as Demand Grows For Obesity Treatments Changes in reimbursement patterns for obesity drugs will take several years. Lifestyle changes remain the first approach. |
American Family Physician
June 1, 2001
James M. Lyznicki |
Obesity: Assessment and Management in Primary Care Obesity is a complex, multifactorial condition in which excess body fat may put a person at health risk. National data indicate that the prevalence of obesity in the United States is increasing in children and adults... |
Fast Company
Christina Farr |
AHA, Alphabet Set Aside $75 Million To Cure Coronary Heart Disease The American Heart Association, Verily (the company formerly known as Google Life Sciences), and European pharmaceutical giant AstraZeneca are investing the funds over a five-year period. |
Pharmaceutical Executive
September 1, 2012
Al Topin |
Doctors' Words No Longer Gospel In the digital age, physicians don't call the shots when it comes to healthcare guidance. Marketers must appeal to multiple sources in seeking ways to garner patient adherence and loyalty. |
Prepared Foods
October 1, 2006
William A. Roberts, Jr. |
Editorial Views -- Rebuilding Seasons Over the past 30 years, overweight and obesity levels have skyrocketed. And Americans have developed a culture of gaining that will not easily disappear. |
Managed Care
March 2000
John A. Marcille |
Smoking's Out, Drugs Passe, So Why Are We Overweight? |
American Family Physician
October 1, 2000
Richard J. Ackermann |
End-of-life Care Withholding or withdrawing life-sustaining therapies is ethical and medically appropriate in some circumstances. This article summarizes the American Medical Association's Education for Physicians on End-of-life Care curriculum module on withholding or withdrawing therapy... |
American Family Physician
February 1, 2005
Searight & Gafford |
Cultural Diversity at the End of Life: Issues and Guidelines for Family Physicians When considering therapeutic options, physicians should consider that members of many cultural groups prefer that family members, rather than patients, make treatment decisions. |
HBS Working Knowledge
November 17, 2003
Martha Lagace |
The Business Case for Diabetes Disease Management Diabetes is a tough disease to tackle. A case-study discussion led by Harvard professor Nancy Beaulieu asked why it is so complex for business and society, and what might be done to curb its incidence. |
IndustryWeek
August 1, 2002
Doug Bartholomew |
Health Care's Shocking Affliction This trillion-dollar industry is shamefully backward when it comes to IT. |
Nurse Practitioner
August 2010
Virginia Sun |
Update on Pancreatic Cancer Treatment Pancreatic cancer is the 10th leading type of all new cancer cases and the fourth leading type of cancer death that affects both men and women. |
Fast Company
April 2012
Lindsey Kratochwill |
How Jay Want Prescribes A Change In The Business Of Paying For Health Care This year, the U.S. government started a program for health-care innovators. One innovator, Jay Want sees a more efficient and cost-effective future for healthcare payments. |
Managed Care
November 2006
Nagel et al. |
Implementing Disease Management Programs for Type 2 Diabetes in Germany Germany has been able to enroll more than a million people with type 2 diabetes in disease management programs through legislation that created incentives for physicians and insurers. |
Nursing Management
March 2010
Becker & Schmidtke |
All along the watchtower: Suicide risk screening, a pilot study Patients will continue to die if healthcare organizations don't take action and appropriately assess patients at risk for suicide in general hospitals. |
Pharmaceutical Executive
September 1, 2012
Robin Hertz |
The Endless Treadmill of End-of-Life Care Bending the cost curve back to valuing the cycle of life. |
Pharmaceutical Executive
September 1, 2012
Ben Comer |
You Tell Me Specialized knowledge about disease and treatment is no longer the exclusive province of practicing physicians. For biopharmaceutical manufacturers, patient feedback can help to elucidate an unmet need. |
Job Journal
July 3, 2005
Julia Hollister |
Nursing: The Pulse of California Healthcare Desperate hospital recruiters up the ante with signing bonuses for RNs and LPNs. In fact, many hospitals, under pressure to lower costs, are using licensed vocational nurses (LVNs) in place of registered nurses wherever allowed. |
American Family Physician
May 15, 2002
Heather McNeill & Sarah Morgan |
Quantum Sufficit Talk to your patients about engaging in moderate exercise, and you may just get them off the couch and on the path to better health... Teens look to the net for information on health issues... Family difficulties can increase the risk of a fatal stroke... etc. |
BusinessWeek
February 4, 2010 |
How Disease Management Works Providers have convinced many big employers that their services save money and improve employee health. |
Pharmaceutical Executive
January 1, 2013
Al Topin |
The Doctor-Patient Disconnect Doctor-patient conversations aren't always what we think; this basic interaction represents both a problem and an opportunity for today's drug marketers, says the author. |
Managed Care
November 1999
Arthur L. Baldwin III |
Financial and Risk Considerations for Successful Disease Management Programs Results for disease management programs have not been as positive as hoped because of clinical issues, lack of access to capital, and administrative issues.... |
American Journal of Nursing
September 2011
Adams & Tolich |
Original Research: Blood Transfusion: The Patient's Experience This study therefore sought to identify how well patients understand the role of blood transfusion in their treatment and whether it causes them discomfort. |
BusinessWeek
June 25, 2009
Catherine Arnst |
The Family Doctor: A Remedy for Health-Care Costs? How making primary-care physicians the center of America's health-care system could drive down costs. |
The Motley Fool
May 30, 2006
Rich Duprey |
NICE Not Playing Nice With Alzheimer's The British health authority proposes limiting availability of Alzheimer's treatments because of cost. What will this mean to drug-makers and their shareholders? |
The Motley Fool
July 13, 2010
Brian Orelli |
A Triple Delight: 3 Stocks All Up More Than 10% What's good for the obese goose is good for the gander when it comes to new drug treatments for losing weight. |
BusinessWeek
September 1, 2009
Catherine Arnst |
Opportunities in the Obesity Epidemic Drugmakers are ratcheting up research into treatments for gout and other ills that plague the overweight. |
American Family Physician
October 15, 2003
Gavin et al. |
Reducing Cardiovascular Disease Risk in Patients with Type 2 Diabetes By increasing patient awareness of the link between diabetes and heart disease, family physicians can encourage patients to take medications (including aspirin), stop smoking, lower blood pressure, and lower cholesterol and blood glucose levels. |
American Family Physician
November 15, 2005
Haas et al. |
Management of the Difficult Patient All physicians must care for some patients who are perceived as difficult because of behavioral or emotional aspects that affect their care. Specific communication techniques and greater patient involvement in the process of care may enhance the relationship. |
BusinessWeek
February 16, 2004
Catherine Arnst |
Medicare vs. Cancer Patients Refusing to reimburse off-label treatment is far from the best way to cut costs. |
Job Journal
January 18, 2009 |
Career Snapshot: Registered Nurse Registered nurses have a wealth of career opportunities to choose from. |
American Family Physician
May 15, 2005
Bhatnagar & Kaplan |
Treatment Options for Prostate Cancer: Evaluating the Evidence Controversy surrounds the management options for localized prostate cancer-conservative management, prostatectomy, and radiation. Choosing among these options is difficult because of long-term side effects that include sexual, urinary, and bowel dysfunction. |
